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Rathke's pouchThe intermediate and anterior lobes of the pituitary gland are derived from an invagination of oral ectoderm
that forms Rathke's pouch. During gestation proliferating cells are enriched around the pouch lumen, and they
appear to delaminate as they exit the cell cycle and differentiate. During latemouse gestation and the postnatal
period, anterior lobe progenitors re-enter the cell cycle and expand the populations of specialized, hormone-
producing cells. At birth, all cell types are present, and their localization appears stratiﬁed based on cell type.
We conducted a birth dating study of Rathke's pouch derivatives to determine whether the location of
specialized cells at birth is correlated with the timing of cell cycle exit. We ﬁnd that all of the anterior lobe cell
types initiate differentiation concurrentlywith a peak between e11.5 and e13.5. Differentiation of intermediate
lobe melanotropes is delayed relative to anterior lobe cell types. We discovered that specialized cell types are
not grouped together based on birth date and are dispersed throughout the anterior lobe. Thus, the apparent
stratiﬁcation of specialized cells at birth is not correlatedwith cell cycle exit. Thus, the currently popularmodel
of cell speciﬁcation, dependent upon timing of extrinsic, directional gradients of signaling molecules, needs
revision.We propose that signals intrinsic to Rathke's pouch are necessary for cell speciﬁcation between e11.5
and e13.5 and that cell–cell communication likely plays an important role in regulating this process.avesper@umich.edu
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The development of the vertebrate neural ectoderm provides a
paradigm for understanding the timing of cell speciﬁcation in relation
to the physical location of cell types. Neural progenitors actively divide
around the lumen of the neural tube, then exit the cell cycle and
migrate towards the periphery where they differentiate into special-
ized cell types. In the neural tube, the earliest born neurons are located
in the ventricular zone, while the later born neurons are located in the
superﬁcial marginal zone (Luskin and Shatz, 1985). The development
of the mouse pituitary gland from the oral ectoderm is similar to the
neural tube in that the progenitors actively divide around the lumen of
Rathke's pouch, the precursor of the pituitary gland (Ikeda and
Yoshimoto, 1991; Ward et al., 2005). As cells on the ventral side of
Rathke's pouch exit the cell cycle they progress to a cyclin-dependent
kinase inhibitor 1 C (p57Kip2) positive, cyclin E positive transitional
stage at the boundary between the lumenal area and the forming
anterior lobe (Bilodeau et al., 2009). These transitional cells then form
the anterior lobe where they express cyclin-dependent kinase
inhibitor 1B (p27Kip1) and intermediate markers of differentiation,
such as TBX19 for corticotropes, before differentiating fully to
hormone expressing cells (Bilodeau et al., 2009; Ikeda and Yoshimoto,1991; Ward et al., 2005). It is not known whether the cells actively
migrate or are passively extruded from the lumenal area. Cells in the
intermediate lobe remain on the dorsal side of the lumen adjacent to
the posterior lobe of the pituitary. These intermediate lobe cells
differentiate into melanotropes, which process pro-opiomelanocortin
(POMC) into melanocyte stimulating hormone (MSH).
The anterior lobe contains specialized cell types that are typiﬁed
by the hormones that they produce: gonadotropes produce luetiniz-
ing hormone (LH) and follicle stimulating hormone (FSH); somato-
tropes produce growth hormone (GH); corticotropes produce
adrenocorticotropin (ACTH), which is processed from POMC; thyro-
tropes produce thyroid stimulating hormone (TSH); and lactotropes
produce prolactin (PRL). At birth the rodent hormone-producing cells
in the anterior lobe of the pituitary gland have a stratiﬁed appearance
such that these speciﬁc cell types are enriched in speciﬁc locations. For
instance, gonadotropes are located at the rostral end of the pituitary,
while somatotropes occupy more caudal positions (Baker and Gross,
1978). The anterior pituitary hormone-producing cells are enriched in
stereotypical homotypic and heterotypic positions in other verte-
brates including birds, ﬁsh, amphibians, and reptiles as well
(Matsumoto and Ishii, 1992). The grouping of the hormone-producing
cells in the pituitary anterior lobe could result from differential timing
of cell speciﬁcation, as in the neural ectoderm, where different cell
types occupying different levels in the neural tube are sequentially
produced from progenitor cells in the ventricular zone. Alternatively,
the organization could result from cell migration to form homotypic
networks (Bonnefont et al., 2005).
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cells labeled at e11.5 are located at more rostral and ventral locations
in the developing anterior lobe than cells labeled at e12.5 (Ward et al.,
2005). Unlike the neural ectoderm, which has an inside out ordering
of cell types based on age, the anterior pituitary appears to have its
earliest born cells located farthest from the lumen. Because gonado-
tropes occupy the most rostral locations, they should be speciﬁed
before somatotropes that occupy the more caudal and lateral
locations. The prediction that gonadotropes are speciﬁed before
somatotropes is not intuitive because gonadotropes are the last cell
type to express markers of completed differentiation (LH is not
detected in gonadotropes until e16.5, while GH is detected in
somatotropes at e15.5) (Japon et al., 1994). Gonadotropes likely
undergo a stepwise progression of differentiation; the ﬁrst gonado-
trope speciﬁc marker, gonadotropin releasing hormone receptor, Gnrhr,
is expressed at e14.5 (Holley et al., 2002), followed by Nr5a1 (SF-1) at
e15.5 (Barnhart and Mellon, 1994), Lhb at e16.5, and Fshb at e17.5
(Japon et al., 1994). While this stepwise differentiation of gonado-
tropes takes longer than the differentiation of somatotropes, the more
rostral location of gonadotropes predicts an earlier commitment to
cell fate.
Neural tube cells that have exited the cell cycle are truly post-
mitotic; they do not re-enter the cell cycle. In contrast, the pituitary
gland increases in size during the late gestational period through the
postnatal period in part through the proliferation of differentiated
anterior lobe cell types and progenitors that have seeded the anterior
lobe (Carbajo-Perez et al., 1989; Carbajo-Perez and Watanabe, 1990;
Taniguchi et al., 2001a, b). However, during gestation, the focus of this
study, the anterior lobe has few proliferating cells relative to the peri-
lumenal area, and themajority of cells that have begun to differentiate
or are fully differentiated are quiescent (Bilodeau et al., 2009;Ward et
al., 2005;Ward et al., 2006). For this study, references to cell cycle exit
will refer to this time period from e11.5 to e17.5, when differentiated
cells have a low proliferation rate.
Current models of cell speciﬁcation in the anterior lobe propose
that opposing gradients of FGF and BMP signaling pattern the
progenitor cells within Rathke's pouch before they move to the
anterior lobe where they differentiate (Burgess et al., 2002; Wagner
and Thomas, 2007). Fgf8 is expressed in the infundibulum, the
precursor of the posterior lobe of the pituitary gland, dorsal to
Rathke's pouch, while Bmp2 is expressed in the ventral portion of
Rathke's pouch at e10.5 (Ericson et al., 1998; Treier et al., 1998).
Ventral cell types in the anterior lobe, such as gonadotropes, are
predicted to arise from ventral locations in Rathke's pouch that
receive high levels of BMP, while dorsal cell types in the anterior lobe,
such as somatotropes, are predicted to arise from dorsal locations in
Rathke's pouch that receive high levels of FGF. Thyrotropes located in
the caudo-medial region of the anterior lobe should arise from areas
with intermediate levels of FGF and BMP in Rathke's pouch. These
models are largely based on gain of function and dominant negative
experiments in transgenic mice and studies with pituitary explants
(Ericson et al., 1998; Treier et al., 1998).
Based on these proposed gradients of FGF and BMP in Rathke's
pouch, the peri-lumenal pattern of progenitor proliferation, and the
preferential location of earlier born cells to occupy more rostral
positions in the anterior lobe, we predicted that the caudal to rostral
location of cell types in the anterior lobe would reﬂect the relative
timing of cell speciﬁcation. For example, rostrally and ventrally
located gonadotropes would exit the cell cycle and begin to
differentiate before caudally positioned somatotropes. We tested
this prediction by birthdating the anterior lobe cell types. We found
that the caudal to rostral location of cell types does not correlate with
the timing of cell cycle exit. In addition, cells that are born
concurrently are dispersed throughout the anterior lobe, instead of
occupying adjacent locations. Therefore, the localized appearance of
cells in the pituitary anterior lobe does not result from the sequentialrelease of specialized cell types from the cell cycle. The apparent
enrichment of cell types in speciﬁc regions of the anterior lobe at birth
is more likely a result of cell movement to establish networks of
speciﬁc cell types than a relationship with timing of cell cycle exit
(Bonnefont et al., 2005). Our ﬁndings suggest that the model for cell
speciﬁcation in the pituitary gland needs revision. Altering the
balance of signaling factors that originate in the ventral diencephalon
does not affect cell speciﬁcation in the anterior lobe (Brinkmeier et al.,
2007; Davis and Camper, 2007; Potok et al., 2008; Rizzoti et al., 2004;
Zhao et al., 2009). Therefore, we present a newmodel for pituitary cell
speciﬁcation that focuses on factors that are intrinsic to Rathke's
pouch when cells begin to differentiate between e11.5 to e13.5,
including the BMP, WNT, and NOTCH signaling pathways.Materials and methods
Mice
Pregnant CD-1 mice were purchased from Charles River and kept
at the University of Michigan utilizing protocols approved by the
University of Michigan Committee on the Care and Use of Animals.
The day a copulation plug was detected was deﬁned as embryonic day
0.5 (e0.5). Pregnant mice received intraperitoneal injections of 100 μg
BrdU per gram of body weight (Nowakowski et al., 1989). At least two
pregnant mice were injected for each embryonic day of development
between e9.5 and e17.5. All embryos were allowed to develop until
e17.5 when they were collected. All embryos were ﬁxed in 3.7%
formaldehyde in phosphate buffered saline (PBS), pH 7.5 overnight at
4 C. Embryos were dehydrated and embedded in parafﬁn (Hogan et
al., 1994).Immunohistochemistry, sampling, and counting
Slides used for immunohistochemistry were dewaxed in xylene
and then hydrated through 100% and 95% ethanol before washing in
PBS. Please see Table 1 for speciﬁcs for each experiment, including
antigen retrieval, peroxidase inactivation, blocking, antibodies used,
and detection methods.
Each e17.5 embryo was embedded in parafﬁn in a coronal
orientation and sectioned at 6 μm in thickness from caudal to rostral.
Placing two sections on each slide generally produced 30 slides
containing pituitary tissue. Each set of 30 pituitary slides was divided
into groups of six slides based on caudal to rostral location. To
prevent bias based on a standardized starting point, the ﬁrst slide
picked from each individual in the most caudal group (slides 1–6)
was picked at random using a random number generator (www.
random.org). This number was then used as the starting point for the
individual and every 6th slide was then selected to generate a set of
ﬁve slides that represented each caudal to rostral grouping. This set
of ﬁve slides was used for one speciﬁc hormone antibody and BrdU
double immunohistochemistry experiment. Additional double im-
munohistochemistry experiments were conducted using sets of ﬁve
slides that followed sequentially from the random starting location.
Three embryos were used for each double immunohistochemistry
experiment.
Results of the immunohistochemistry experiments were observed
on a Leica DMRB microscope at ﬁnal magniﬁcation of 630× and
photographed using a Retiga 2000R digital camera. Each image
compilation was manually counted using Image Pro Plus software
(Media Cybernetics). Due to the large number of samples necessary to
conduct this experiment, it was not possible to process all of the slides
at the same time. Therefore, the data were expressed as a proportion
of the total for each experiment in order to limit the affect of
variability inherent between immunohistochemistry experiments.
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Proportions of double-labeled cells (# BrdU and hormone double
positive cells/total # hormone positive cells) were transformed with
the logit-function [logit(p)= ln(p/(1− p)) where p is the proportion
of double-labeled cells]. One-way ANOVA with Tukey adjustments
was used to compare the means of speciﬁc populations, either across
time points or locations. Level of signiﬁcance was set at pb0.05.
Determination of the timing of proliferation used the mean of total
BrdU positive cells counted per time point. The distribution of this
data was roughly normally distributed and was not transformed. All
calculations were performed using SAS 9.1 (SAS Institute).
Results
We tested the hypothesis that the caudal to rostral location of cells
within the anterior lobe of the pituitary gland is predictive of the
relative time of cell cycle exit. If this hypothesis were true, then rostral
cells would be born before caudal cells. BrdU was used to label
proliferating cells on each embryonic day of development between
e9.5 and e17.5. All embryos were allowed to develop until e17.5,
when the majority of anterior pituitary hormones can be detected.
The number of BrdU positive cells present at e17.5 is dependent on a
variety of factors including the proliferative index of the pituitary,
which could differ during development, the amount of BrdU that is
retained within cells that continue to divide, the changing size of the
developing pituitary gland, and the potential loss of cells during
development. Those cells that retain the BrdU likely exited the cell
cycle shortly after incorporating the BrdU and began to differentiate.
Those cells that continued to proliferate would have diluted BrdU
labeling, although it is not clear how many cell divisions are required
before the BrdU is undetectable. The population of BrdU labeled cells
should be representative of those cells that exited the cell cycle
shortly after incorporating the BrdU for each day that BrdU was
injected. Immunohistochemistry was used to detect GH for somato-
tropes, POMC for corticotropes and melanotropes, TSH for thyro-
tropes, and LH for gonadotropes in conjunction with a BrdU antibody
to determine the relative timing of cell cycle exit for each cell type.
The lactotrope population was not examined because prolactin
expression is estrogen dependent and is not readily detectable until
after birth (Ogasawara et al., 2009; Slabaugh et al., 1982). Folliculo-
stellate cells are also only detectable post partum, and were not
examined in this study (Soji et al., 1997).
Timing of anterior lobe cell cycle exit
At e17.5 pituitary cells labeled with BrdU at e9.5 and e10.5 were
undetectable (data not shown), suggesting that pituitary progenitors
underwent numerous cell divisions subsequent to incorporation of
label. BrdU incorporated at e11.5 was detectable at e17.5 (Fig. 1A, this
panel is a double immunohistochemistry for both BrdU and POMC). In
order to determine when the majority of cells in the anterior lobe exit
the cell cycle the average number of cells that incorporated BrdU per
area of anterior lobe at e17.5 was determined for each day of
development between e11.5 and e17.5 when BrdU was injected
(Fig. 2A). One-way ANOVA was used to assess signiﬁcance at pb0.05
(Fig. 2B). The highest rates of incorporation in the anterior lobe
occurred between e11.5 and e14.5. Because anterior lobe cells are
generally not dividing, these cells must have exited the cell cycle
shortly after incorporating BrdU and begun the differentiation
process.
Anterior lobe cell type distribution
While the regional enrichment of cell types in the pituitary
anterior lobe at birth has been reported previously (Baker and Gross,
Fig. 1. Corticotropes begin to differentiate early in pituitary oraganogenesis. (A–G) Immunohistochemistry for POMC (green), and BrdU (red), and counter-stained with DAPI (blue).
BrdUwas injected on e11.5 (A), e12.5 (B), e13.5 (C), e14.5 (D), e15.5 (E), e16.5 (F), and e17.5 (G) and the assay performed for all images at e17.5. Arrows highlight selected cells that
are positive for both POMC and BrdU. All sections are coronal with dorsal towards the top and medial on the right. (H) Lower magniﬁcation of F with the area depicted in F boxed.
a=anterior lobe; i=intermediate lobe; p=posterior lobe. (A–G) Similar regions of the pituitary in their respective embryos. Similar results were observed for LH, TSH, and GH
(supplemental ﬁgures 2–4). Scale bars equal 100 um. Scale bar in G applies to A–F.
218 S.W. Davis et al. / Developmental Biology 352 (2011) 215–2271978), it has not been quantitatively assessed. Therefore, we
quantiﬁed the distribution of cell types along the caudal to rostral
axis by determining the proportion of the total number of cells located
along the axis for each cell type (Fig. 3A). Gonadotropes are
preferentially located at more rostral locations within the anterior
lobe, while somatotropes are the most caudally located cell type
(Fig. 3B). Corticotropes and thyrotropes occupy more intermediate
locations (Fig. 3B). About 10% of both corticotropes and thyrotropesare located at the rostral end of the pituitary (Fig. 3A). This percentage
is signiﬁcantly different from the other locations for corticotropes,
while it is not for thyrotropes. Our interpretation is that both
corticotropes and thyrotropes are preferentially located in interme-
diate locations in the anterior lobe with a lower representation at the
most rostral end. Cell types are not precisely stratiﬁed. Instead, each
cell type is enriched in certain locations along the caudal to rostral
axis, but they are not excluded from any location.
AB
Significant groupings from one-way ANOVA
Group A  e12.5, e13.5, e14.5 
Group B  e11.5, e13.5, e14.5, e16.5  
Group C  e15.5, e16.5, e17.5 
F( 6, 13) = 17.62, p < 0.0001, R2 = 0.891
Fig. 2. Peak BrdU incorporation occurs early in pituitary organogenesis. (A) The average
number of BrdU positive cells per mm2 of anterior lobe tissue for three individuals was
determined for each embryonic day of BrdU injection. Error bars represent the standard
deviation. (B) Signiﬁcant groupings as determined by one-way ANOVA. F (model
degree of freedom, error degree of freedom)=F value.
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Based on the higher rate of proliferation from e11.5 to 14.5 and the
spatial distribution of anterior lobe cell types, we asked whether the
birthdates of hormone-producing cells exhibit unique temporal–
spatial features. For each anterior and intermediate lobe cell type the
timing of cell cycle exit and transition to differentiation was examinedFig. 3. Gonadotropes are located more rostrally than somatotropes. (A) The total
number of hormone positive cells was determined for each cell type listed. The
proportion of the total for each cell type was determined for each caudal to rostral
location across the pituitary. Points represent the mean for three individuals for each
cell type and error bars represent the standard deviation. (B) Signiﬁcant groupings as
determined by one-way ANOVA.by determining the proportion of each hormone-producing cell type
that incorporated and retained BrdU between embryonic days e11.5
and e17.5. Fig. 1 contains representative data for BrdU and POMC,
where BrdU+/POMC+ cells are readily identiﬁable at e11.5, e12.5,
and e13.5 (Fig. 1A–C), but are less numerous from e14.5 to e17.5
(Fig. 1D–G, see Supplemental ﬁgure 1 for immunohistochemistry
control experiments). Similar data were observed for LH, TSH, and GH
(Supplemental ﬁgures 2–4). For each hormone the proportion of
BrdU+/Hormone+ cells out of the total number of hormone cells
was determined (Fig. 4A). One-way ANOVA analysis was used to
identify signiﬁcant groupings for each cell type (Fig. 4B). The e11.5
to e12.5 time point is when gonadotropes and thyrotropes are
primarily speciﬁed. Corticotropes and somatotropes have a broader
range of speciﬁcation from e11.5 to e13.5, which overlaps with the
gonadotropes and thyrotropes. There is no signiﬁcant difference
between the proportion of cells speciﬁed on each day within these
groupings, i.e. similar proportions of somatotropes are likely to be
speciﬁed on e11.5, e12.5, and e13.5. We conclude that all anterior
lobe cell types begin the differentiation process concurrently, rather
than in a temporally discrete manner.
We extended our analysis to include the intermediate lobe
melanotropes. Melanotropes do not enter the anterior lobe, but
remain on the dorsal side of the lumen. We found that melanotropesFig. 4. Pituitary gland birthdating reveals that differentiation of melanotropes occurs
after anterior lobe cell types. (A) The total number of BrdU and hormone double-
labeled cells was determined for each cell type listed, as well as the total number of
hormone positive cells. The bars represent the mean proportion of BrdU and hormone
double-labeled cells out of the total hormone population for three individuals for each
embryonic day of BrdU injection. Error bars represent the standard deviation. (B)
Signiﬁcant groupings as determined by one-way ANOVA.
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types (Fig. 4A and B, Supplemental ﬁgure 5). This result suggests that
Rathke's pouch progenitors have a preference for producing anterior
lobe cell types before intermediate lobe melanotropes.Anterior lobe hormone-negative cell cycle exit
The pituitary contains a population of cells that do not express any
detectable hormone (Senovilla et al., 2008). We sought to birthdate
this hormone-negative population. We performed immunohisto-
chemistry using the primary antibodies for GH, LH, TSH, and POMC
concurrently and visualized the entire hormone-producing popula-
tion with the same ﬂuorophore. We measured the proportion of
double-labeled BrdU and hormone positive cells out of the total BrdU
positive cells to reveal when all hormone-producing cell types are
born (Fig. 5A, Supplemental ﬁgure 6). BrdU labeled anterior lobe cells
that do not express hormone represent the hormone-negative cell
population. As expected based on the results of birthdating with
individual anterior lobe hormone antibodies, the largest proportion of
BrdU labeled “all hormone” cells arise between e11.5 and e13.5
(Fig. 5A and B). While some e17.5 double-labeled “all hormone” cells
are speciﬁed after e13.5, most of the cells that incorporated BrdU after
e13.5 did not express any hormone. The hormone-negative cellsFig. 5.Most cells born after e13.5 do not express any hormones. (A) The total number of BrdU
total number of BrdU positive cells. The bars represent the mean proportion of double-labe
embryonic day of BrdU injection. Error bars represent the standard deviation. (B) Signiﬁcan
TBX19 (green) and POMC (yellow). POMC was detected with Cy3, but appears yellow b
immunohistochemistry for NR5A1 (green) and LH (red). Arrow indicates a NR5A1 positive ce
and TSH (red). A Cy3 secondary was used to detect both GH and TSH. Arrow indicates a POUmaybe a mixture of undifferentiated progenitors and incompletely
differentiated, but committed cells.
We assessed the relative proportion of incompletely differentiated,
but committed cells by performing a double immunohistochemistry
for transcription factors that identify separate lineages and a hormone
speciﬁc to that lineage. All cells that expressed TBX19 (TPIT) also
expressed POMC, indicating that there are few corticotropes that are
not fully differentiated (Fig. 5C). The gonadotropes were analyzed
using an antibody against NR5A1 (SF1) and LH. Most NR5A1 positive
cells were also LH positive (Fig. 5D). However, a few cells were NR5A1
positive and LH negative, indicating either that these cells will
eventually express LH, but have not fully differentiated or that these
cells may represent a transitional cell type that expresses both FSH
and TSH (Wen et al., 2010). The large proportion of hormone-negative
cells cannot be accounted for by the few incompletely differentiated
gonadotropes. Next we analyzed the Pit1 lineage by performing a
double immunohistochemistry for POU1F1 (PIT1) with GH and TSH
combinedwith the same ﬂuorophore (Fig. 5E). Many POU1F1 positive
cells were identiﬁed that did not express detectable levels of
hormone, suggesting that partially differentiated cells of the Pit1
lineage are present in the embryonic pituitary gland. These cells may
represent the lactotrope cells that will begin PRL expression after
birth and/or somatotropes, which substantially increase in number
after birth.cells double labeled with either ACTH, GH, LH, and TSH was determined, as well as the
led cells out of the total BrdU positive population for each of three individuals for each
t groupings as determined by one-way ANOVA. (C) Double immunohistochemistry for
ecause of the cross-reaction from using two antibodies raised in rabbit. (D) Double
ll that is negative for LH. (E) Double immunohistochemistry for POU1F1 (green) and GH
1F1 positive cell that is negative for GH and TSH. Scale bar in E equals 100 μm for C– E.
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SOX2 is a marker of stem cells in a variety of tissues. In the
pituitary, SOX2 marks a population of cells that line the lumen from
formation of Rathke's pouch into adulthood (Chen et al., 2009;
Fauquier et al., 2008; Garcia-Lavandeira et al., 2009). Pituispheres
cultured from adult pituitaries that can differentiate into all anterior
lobe cell types also express SOX2, suggesting that these lumenal SOX2
cells may represent a pituitary stem cell population (Fauquier et al.,
2008). SOX2 is also found throughout the anterior lobe, but this
population of cells is also SOX9 positive and is thought to represent a
population of early progenitor cells (Fauquier et al., 2008). Therefore,
we examined the proliferation of SOX2 positive cells that are located
adjacent to the lumen in the proposed stem cell niche (Fig. 6A).
Throughout embryonic pituitary organogenesis, a steady proportion
of SOX2 positive cells are in a proliferative state (Fig. 6B, Supplemental
ﬁgure 7).Fig. 7. Hormone-producing cells born on e12.5 are scattered throughout the anterior
lobe. (A) The proportion of double-labeled BrdU and hormone positive cells out of the
total number of hormone cells was determined for each location across the caudal to
rostral axis when BrdU was injected on e12.5. Points represent the mean proportion for
three individuals for each hormone indicated. Error bars represent the standard
deviation. (C) Signiﬁcant groupings as determined by one-way ANOVA.Spatial location of BrdU positive and hormone positive cells
Most of the hormone expressing cell types appear to stop
proliferating and differentiate between e11.5 and e14.5 rather than
in a sequential pattern of discrete times. Despite this broad range of
birthdates, anterior lobe cell types may be stratiﬁed based on the time
of cell cycle exit. To examine this possibility, we graphed the
proportion of BrdU and hormone double-labeled cells out of the
total hormone population across the caudal to rostral axis when BrdU
was injected on e12.5 (Fig. 7A). We found no enrichment of double-
labeled cells at any caudal to rostral location for thyrotropes and
corticotropes; instead, double-labeled cells for each cell type were
distributed across the caudal to rostral axis (Fig. 7B). This is also true
for somatotropes and gonadotropes except that double-labeled cells
were not abundant in the caudal (gonadotropes) or rostral (somato-
tropes) ends of the pituitary. An even distribution of double-labeled
cells for all anterior lobe cell types was also observed on all other days
of BrdU incorporation (data not shown).
In order to extend the spatial analysis of differentiated anterior
lobe cells, we examined the caudal to rostral distribution of anterior
lobe cells by embryonic day of BrdU incorporation. For instance, cells
born on e11.5 should be foundmore rostrally than cells born on e13.5,
regardless of cell type, if the anterior lobe is stratiﬁed based on the
timing of cell cycle exit. We found that BrdU positive cells are
uniformly distributed across the pituitary for all days of BrdU
incorporation (Fig. 8A and B). Therefore, the timing of cell cycle exitFig. 6. SOX2 progenitor cells are constantly dividing throughout pituitary organogenesis. (A)
and BrdU double positive cells that are adjacent to the lumen and were counted as poten
adjacent to the lumen and was not counted as a potential stem cell. Scale bar equals 100 μm.
the total number of SOX2 positive cells. The bars represent themean proportion of BrdU and
embryonic day of BrdU injection. Error bars represent the standard deviation. (C) Signiﬁcandoes not result in a spatial pattern of specialized anterior lobe cell
types across the caudal to rostral axis.Distribution of BrdU positive cells in the dorsal to ventral and medial to
lateral axes
The gradients of FGF and BMP that are thought to regulate cell
speciﬁcation in the pituitary are distributed across the dorsal to
ventral axis of Rathke's pouch (Ericson et al., 1998; Treier et al., 1998).
Therefore, the dorsal to ventral axis may be the more appropriate axis
for examining the stratiﬁcation of the anterior lobe. In order to
address this possibility we examined the location of BrdU positive
cells in coronal sections of e17.5 embryos for BrdU injected at each
embryonic day between e11.5 and e17.5 (Fig. 9A–G). We did notDouble immunohistochemistry for SOX2 (green) and BrdU (red). Arrows indicate SOX2
tial stem cells. Arrowhead indicates a SOX2 and BrdU double positive cells that is not
(B) The total number of BrdU and SOX2 double-labeled cells was determined, as well as
SOX2 double-labeled cells out of the total SOX2 population for three individuals for each
t groupings as determined by one-way ANOVA.
Fig. 8. Anterior lobe cells that differentiate concurrently are dispersed throughout the
caudal to rostral axis of the anterior lobe. The total number of BrdU positive cells was
determined for each daywhen BrdUwas injected from e11.5 to e17.5. The proportion of
the total for each day of BrdU injection was determined for each caudal to rostral
location across the pituitary. Points represent the mean for three individuals for each
cell type. Error bars represent the standard deviation. (C) Signiﬁcant groupings as
determined by one-way ANOVA for the e12.5 BrdU injection day.
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ventral side, regardless of the date of BrdU injection. Nor did we
observe an enrichment of BrdU cells on the medial to lateral axis.
Therefore, the enrichment of speciﬁc cell types within regions of the
anterior pituitary gland at birth does not result from the ordered
release from the cell cycle of cell types during pituitary organogenesis.
The distribution of cell types must result from amechanism unrelated
to the timing of cell cycle exit.Temporal and spatial analysis of BMP and FGF signaling
We have shown that anterior lobe cell types exit the cell cycle
between e11.5 and e13.5. If gradients of BMP and FGF signaling are
necessary for specifying anterior lobe cell types (Burgess et al., 2002;
Wagner and Thomas, 2007), then these signaling pathways should be
present in the pituitary at this time. We examined the phosphoryla-
tion status of SMADs 1, 5, and 8 (pSMAD), common intracellular
transducers of BMP signaling, to assess the existence of signaling
gradients (Brinkmeier et al., 2007; Davis and Camper, 2007). At e10.5,
pSMAD is enriched on the ventral side of Rathke's pouch in a domain
consistent with Bmp2 expression (Fig. 10A) (Ericson et al., 1998;
Treier et al., 1998). By e11.5, pSMAD is found throughout Rathke's
pouch, consistent with the expansion of Bmp2 throughout Rathke's
pouch at this time (Fig. 10C) (Treier et al., 1998). A uniform
distribution of pSMAD is also evident at e12.5 except that scattered
cells in the lumenal area and forming anterior lobe have more intense
staining (Fig. 10E). This pattern persists at e13.5, but there is an
overall decrease in pSMAD intensity (Fig. 10G). At e14.5, cells on the
dorsal side of the lumen have little to no pSMAD staining, while the
anterior lobe maintains a fairly uniform level of pSMAD signal
(Fig. 10I). Therefore, there is little evidence for a gradient of BMP
signaling when anterior lobe cell types exit the cell cycle between
e11.5 and e13.5. Instead, BMP signaling is found throughout Rathke's
pouch at this time.
In order to characterize the affect of FGF signaling on Rathke's
pouch, we examined the phosphorylation status of MAPK (pMAPK),an intracellular mediator of FGF signaling, from e10.5 to e14.5 in the
pituitary (Davis and Camper, 2007). At e10.5, pMAPK immunoreac-
tivity is enriched on the dorsal side of Rathke's pouch (Fig. 10B),
adjacent to the forming infundibulum, where Fgf8 and Fgf10 are
expressed (Ericson et al., 1998; Treier et al., 1998; Yamasaki et al.,
1996). At e11.5, pMAPK has decreased, but is still dorsally located
(Fig. 10D). From e12.5 to e14.5 pMAPK is not detectable in the
forming pituitary gland (Fig. 10F, H, and J). A gradient of FGF signaling
is apparent at e10.5 before cell speciﬁcation is evident. Between e11.5
to e13.5, when anterior lobe cells exit the cell cycle, little to no FGF
signal is detectable in Rathke's pouch.
Discussion
Current models for pituitary cell speciﬁcation predict that the
stratiﬁed appearance of cell types in the anterior lobe results from an
ordered speciﬁcation of cell types that develop from interacting
gradients of BMP and FGF (Burgess et al., 2002; Wagner and Thomas,
2007). These models also predict that cells born concurrently will
occupy the same location within the anterior lobe. Our results
demonstrate that this is not the case. The enrichment of cell types
at speciﬁc positions along the caudal to rostral axis in newborn mice
does not result from an ordered cell cycle exit for each cell type.
Instead, cells that exit the cell cycle concurrently are dispersed
throughout the anterior lobe of the pituitary. Therefore, the
enrichment of cell types in speciﬁc regions of the anterior lobe results
from a mechanism other than the timing of cell cycle exit, and may
occur through active or passive cell movements, formation of
networks, or control of ﬁnal differentiation by lateral inhibition.
Timing of cell cycle exit
Our results indicate that the majority of the anterior lobe
hormone-producing cells exit the cell cycle between e11.5 and
e13.5. These results are in close agreement with a birthdating study
of anterior pituitary cell types that labeled cycling cells with tritiated
thymidine (Seuntjens and Denef, 1999). Seuntjens and Denef did not
examine cell speciﬁcation at e11.5, but they determined that the
anterior lobe cell types are speciﬁed between e12.5 and e13.5. Our
two reports are in agreement: cell cycle exit for all anterior lobe cell
types occurs concurrently. Individual cell types do not exit the cell
cycle at discrete time points, as suggested by the enrichment of cell
types in regions of the anterior lobe at birth. Our analysis is more
extensive, considering anterior lobe cells that do not produce
hormone, intermediate lobe melanotropes, and SOX2 expressing
progenitor cells. The majority of cells in the anterior pituitary that do
not express detectable levels of hormone at e17.5 express POU1F1.
We predict that these POU1F1 positive, hormone-negative cells are
likely to be lactotropes that are primed to produce PRL after birth and
somatotropes, which increase in number postnatally. In addition, the
hormone-negative population contains a few gonadotropes and is
likely to contain a variety of other cell types that were not detected in
our assay, including multipotential progenitors, folliculo-stellate cells,
and endothelial cells.
While the anterior lobe cell types exit the cell cycle concurrently,
the intermediate lobe melanotropes are delayed in cell cycle exit until
after the anterior lobe cell types. The NOTCH signaling pathway is
necessary for maintaining the progenitor state of cells in the
developing pituitary gland. In the absence of Hes1, a key intracellular
transducer of NOTCH signals, cells in the pituitary gland prematurely
differentiate, which leads to a hypoplastic pituitary (Kita et al., 2007;
Raetzman et al., 2007). In addition, somatotropes are ectopically
formed in the intermediate lobe at the expense of melanotropes
(Raetzman et al., 2007). This conversion of melanotropes to somato-
tropes can be explained by the timing of cell speciﬁcation. If the
pituitary has a pool of progenitors that gives rise to all anterior and
Fig. 9. Anterior lobe cells that differentiate concurrently are also dispersed throughout the dorsal to ventral and medial to lateral axes. BrdU was injected on e11.5 (A), e12.5 (B),
e13.5 (C), e14.5 (D), e15.5 (E), e16.5 (F), and e17.5 (G) and immunohistochemistry was performed at e17.5 for all images. Autoﬂuorescent blood cells appear yellow as the image is a
composite of exposures taken using both red and green ﬁlters. All images are coronal with medial on the right. Each image represents one half of the pituitary gland. Cells
incorporating BrdU at each time point are distributed throughout the gland at e17.5 without being enriched in any preferred location. Scale bar equals 100 μm for all images.
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reduce the size of this common progenitor pool (Kita et al., 2007;
Raetzman et al., 2007). The anterior lobe cell types will be
preferentially generated because they are speciﬁed earlier than the
intermediate lobe melanotropes. Therefore, the progenitor pool may
be depleted before melanotropes arise from the common progenitor
pool. While cells located in the intermediate lobe have the potential to
form multiple anterior lobe cell types (Pulichino et al., 2003), it
appears that cell speciﬁcation likely relies on other cues intrinsic to
Rathke's pouch as premature release from the cell cycle is not
permissive for the formation of all cell types (Kita et al., 2007;
Raetzman et al., 2007).
Recent reports demonstrate that SOX2 positive cells that line the
lumen of the pituitary are a progenitor/stem cell population for the
anterior pituitary (Chen et al., 2009; Fauquier et al., 2008; Garcia-
Lavandeira et al., 2009). We found that these cells are in a steady
proliferative state throughout pituitary organogenesis. The prolifer-
ative status of these SOX2 positive cells is consistent with the idea that
they are a progenitor cell population that yields a variety of pituitary
cell types. We expect that the proliferative rate of SOX2 positive cells
declines after birth as this population of cells transitions to a “stem
cell”-like function necessary for maintaining the pituitary gland in
response to physiological need.Distribution of anterior lobe hormone-producing cells
We analyzed the location of anterior lobe cell types based onwhen
they begin to exit the cell cycle and differentiate. We anticipated that
cells that exit the cell cycle at the same time would be closely
associated with each other along the rostral to caudal axis. Instead, we
found that cells that exit the cell cycle concurrently are scattered
throughout the anterior lobe of the pituitary. Therefore, the
mechanism for enriching cell types in regions of the anterior lobe is
not correlatedwith cell cycle release. Instead directed cell movements
may enrich cell networks. Bonnefont et al. demonstrated that the
somatotropes preferentially coalesce in the lateral wings of the
anterior pituitary and that these networks of somatotropes are very
dynamic and change over time as physiological demand changes
(Bonnefont et al., 2005). The mechanism of producing this network is
unknown, but we speculate that the active movement of cells from
the lumenal area and into the anterior lobe is necessary for producing
this network.
The nature of the signals that lead to the formation of cell type
speciﬁc networks in the pituitary is an unanswered question.
Interestingly, releasing hormones from the hypothalamus may play
a role in forming or maintaining these networks. Navratil et al. (2007)
have shown that gonadotropin releasing hormone (GnRH) causes
Fig. 10. pSMAD signaling, but not pMAPK signaling, is observed in Rathke's pouch during pituitary cell speciﬁcation. Immunohistochemistry for phosphorylated Smad 1, 5, and
8 (A, C, E, G, and I) and phosphorylated MAPK (B, D, F, H, and J). Time points assayed are e10.5 (A, B), e11.5 (C, D), e12.5 (E, F), 13.5 (G, H), and e14.5 (I, J). All sections are sagittal
with dorsal at the top and rostral at the left. Scale bar equals 100 μm for all images.
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that gonadotropes will actively move toward GnRH. GnRH attraction
may stimulate movement of gonadotropes towards the vascular
system in order to enhance release of gonadotropins into the blood
stream. Localized release of GnRH within the pituitary could cause or
reinforce the gonadotrope network at the rostral end of the pituitary.
Cell cycle exit and cell fate commitment
At e13.5 there is a zone of non-cycling, undifferentiated progeni-
tors, primarily on the ventral side of the lumen. These cells express
p57Kip2 and cyclin E and do not express transcription factors
diagnostic for anterior lobe cell types, such as TBX19, SF1, or
POU1F1. As these cells differentiate they express p27Kip1 and the
signature transcription factors of differentiation. Differentiated cells
expressing p27Kip1 are found in more rostral locations in the anterior
lobe (Bilodeau et al., 2009). Our data demonstrate that the majority of
the anterior lobe cells exit the cell cycle between e11.5 and e13.5,
although it does not indicate where or when the commitment into
speciﬁc cell types occurs. The transitional zone identiﬁed by Bilodeau
et al. is likely to be the correct time and place for cell fate commitment
in the anterior lobe. Our data are in agreement with the interpretation
that the last embryonic mitotic division for the majority of the
hormone-producing cells occurs prior to the appearance of p57Kip2 at
e13.5. Commitment to a speciﬁc cell type for these cell cycle arrested
cells may occur in this transitional zone. As these cells differentiate
not only do they turn on cell type speciﬁc genes, but also actively
arrange themselves into networks within the anterior lobe.
Early in rodent development, the proliferating cells appear to line
the lumen of Rathke's pouch and the majority of anterior lobe cells
appear to have exited the cell cycle (Bilodeau et al., 2009; Ikeda and
Yoshimoto, 1991; Ward et al., 2005). During the postnatal period,
many differentiated, hormone expressing cells start proliferating as
the pituitary grows (Carbajo-Perez et al., 1989; Taniguchi et al.,
2001a, b). This postnatal growth period is driven in part by the
mitogenic effects of the hypothalamic releasing hormones (Alba and
Salvatori, 2004; Muglia et al., 1995; Shibusawa et al., 2000). Because
the hypothalamic releasing hormones do not have a mitogenic affect
on anterior lobe cell types before birth, different factors must
stimulate re-entry into the cell cycle during development. The nature
of these stimulating factors is not yet known, but they may be
introduced by the vascular network, which develops in the rodent
anterior lobe around e14.5 (Szabo and Csanyi, 1982). Consistent with
this idea, Prop1 mutants have a deﬁcient vascular network and have
a hypoplastic anterior pituitary at birth, while Pou1f1 mutants have
an intact vascular network and a normal sized anterior pituitary at
birth (Ward et al., 2006).
The commitment to a speciﬁc cell type may occur while the
Rathke's pouch progenitors are still cycling in the peri-lumenal area
before they enter the transition zone. This idea would be similar to the
commitment of somites to speciﬁc vertebral column morphologies
based on their anterior to posterior location and corresponding Hox
gene expression (Kieny et al., 1972; Nowicki and Burke, 2000). This
scenario is supported by the proposed gradients of FGF and BMP
signaling at e10.5 in Rathke's pouch, which may establish different
identities within the pouch for each cell type using a graded series of
transcription factors expressed across the pouch, including Foxl2, Isl1,
and Pou3f4 on the ventral side and Nkx3-1, Six3, and Prop1 on the
dorsal side (Treier et al., 1998).
Gradients in Rathke's pouch
We examined the expression of pMAPK and pSMAD to determine
the temporal and spatial activity of FGF and BMP gradients in the
developing pituitary. The only time that a gradient of these
intracellular factors is observed in Rathke's pouch is at e10.5. At thistime point Bmp2 expression is initiated in the ventral portion of
Rathke's pouch in a domain consistent with pSMAD expression. This
gradient is lost at e11.5 as Bmp2 expression expands to encompass the
entire pouch (Treier et al., 1998). Similarly, a gradient of pMAPK is
detected at e10.5, but decreases afterwards. Anterior lobe cell types
exit the cell cycle between e11.5 to e13.5, when gradients of FGF and
BMP signaling are not detectable. Therefore, it seems unlikely that
these proposed gradients would affect cell fate at this time point.
While pMAPK and pSMAD are certainly well known intracellular
transducers of cell signaling, they are not the only intracellular
transducers of these signaling factors. Therefore, it is possible that the
presence of a gradient could be observed through other intracellular
signaling factors. However, given the expression of Bmp2 throughout
Rathke's pouch at e11.5, and the continued expression of Bmp4 in the
infundibulum at e14.5 in a domain coincident with Fgf 8 and Fgf10
expression (Davis and Camper, 2007; Treier et al., 1998), it is unlikely
that opposing gradients of BMP and FGF are driving cell fate
commitment between e11.5 to e13.5. However, Rathke's pouch does
have regionally expressed transcription factors, suggesting that a
gradient of activity is in effect. Other extrinsic signaling pathways
including SHH or retinoic acid could potential establish the restricted
expression of these transcription factors.
The absence of a FGF or BMP gradient from e11.5 to e13.5 does not
indicate whether commitment to cell fate occurs before or after cell
cycle exit. However, in vivo analyses that alter ventral diencephalon
expression of BMP and FGF signaling, such as noggin−/−, Tcf7l2−/−,
Wnt5a−/−, Sox3−/−, and Lhx2−/− mice, demonstrate that altering the
level of BMP and FGF signaling prior to e11.5 can change the size,
location, and shape of Rathke's pouch, but does not alter cell
speciﬁcation per se (Brinkmeier et al., 2007; Davis and Camper,
2007; Potok et al., 2008; Rizzoti et al., 2004; Zhao et al., 2009).
Therefore, we believe that cell speciﬁcation in Rathke's pouch occurs
through intrinsic signals beginning at e11.5. Because BMP2 is
expressed throughout Rathke's pouch at e11.5 it could play a role
in cell speciﬁcation. The NOTCH signaling pathway is another
intrinsic pathway that affects cell speciﬁcation. In fact, loss of Hes1,
a transducer of NOTCH signaling, causes a cell fate switch of
melanotropes to somatotropes (Raetzman et al., 2007). Recent
results in zebraﬁsh demonstrate that NOTCH can control the number
of cells speciﬁed in different domains of the anterior pituitary. For
instance, NOTCH signaling can promote lactotrope speciﬁcation at the
expense of the corticotropes in the most anterior domain and
somatotropes at the expense of thyrotropes in the posterior domain
of the anterior lobe (Dutta et al., 2008). A similar role for NOTCH
signaling in mice has not been explored completely, but it is clear that
NOTCH signaling plays diverse roles in the mouse pituitary. Hes6 is
expressed in anterior lobe in a domain separate from Hes1,
suggesting that Hes6 may play a role in the differentiation process
while Hes1 maintains the progenitor pool (Raetzman et al., 2004).
Also, the NOTCH ligand Dll3 is expressed in the forming corticotropes
and may play a role in their differentiation, although it is not essential
(Raetzman et al., 2004).
We propose a new model for pituitary gland development that
incorporates our determination of the timing of cell cycle exit for
hormone-producing cells with the need to identify intrinsic factors
necessary for cell speciﬁcation (Fig. 11). At e9.5 Bmp4 expressed in the
ventral diencephalon induces the oral ectoderm to invaginate to form
Rathke's pouch (Takuma et al., 1998). FGF signaling from the ventral
diencephalon is necessary to ensure the continued proliferation of
Rathke's pouch (De Moerlooze et al., 2000; Takuma et al., 1998). A
careful balance of BMP, FGF, and WNT signaling in the ventral
diencephalon results in the proper location and size of Rathke's pouch
(Brinkmeier et al., 2007; Davis and Camper, 2007; Potok et al., 2008;
Rizzoti et al., 2004; Zhao et al., 2009). At e10.5 Bmp2 begins its
expression on ventral side of Rathke's pouch. A gradient of ventral to
dorsal BMP and dorsal to ventral FGF at e10.5 may specify the rostral
Fig. 11. Proposed model for pituitary gland development. (A) Spatial representation of extrinsic and intrinsic factors that inﬂuence development of Rathke's pouch (Bilodeau et al.
observed the transition zone of p57+ cells at e13.5, unpublished observations indicate that this transition zone is present at e14.5 as well (M. Brinkmeier personal communication)).
(B) Balance of extrinsic factors at e10.5 necessary for Rathke's pouch development and known transcription factors that drive differentiation of anterior lobe cell types at e12.5 and
e14.5. (C) Enrichment of cell types in the pituitary gland at e17.5 that results from the sorting of cells into networks following cell speciﬁcation.
226 S.W. Davis et al. / Developmental Biology 352 (2011) 215–227tip thyrotropes on the ventral side, while the progenitors for the
remaining cell types of the anterior and intermediate lobes remain
unspeciﬁed in dorsal locations. At e11.5 the somatotropes, thyro-
tropes, lactotropes, corticotropes, and gonadotropes begin to exit the
cell cycle. As cells exit the cycle they become speciﬁed, possibly by
intrinsic signals such as NOTCH signaling, which is initially established
by Prop1 (Raetzman et al., 2004), and potentially BMP2 and WNT
signaling as well (Potok et al., 2008). At e13.5 this zone of speciﬁcation
ismarked by p57Kip2 and cyclin E in a domain just ventral to the lumen
(Bilodeau et al., 2009). Once cell speciﬁcation occurs these cells sort
themselves into functional networks bymigrating to speciﬁc locations
throughout the anterior lobe (Bonnefont et al., 2005). The sorting of
cells in the anterior lobe rearranges the cells such that cells that exit
the cell cycle concurrently are not necessarily located next to each
other. The apparent stratiﬁcation of the anterior lobe at e17.5 is,
therefore, not a product of an ordered exit from the cell cycle, but of
active movements of cells to preferred locations necessary for
generating cell type speciﬁc networks.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.01.010.
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